Eugene H. Makela

762 total citations
21 papers, 529 citations indexed

About

Eugene H. Makela is a scholar working on Psychiatry and Mental health, Endocrinology, Diabetes and Metabolism and Clinical Psychology. According to data from OpenAlex, Eugene H. Makela has authored 21 papers receiving a total of 529 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Psychiatry and Mental health, 7 papers in Endocrinology, Diabetes and Metabolism and 4 papers in Clinical Psychology. Recurrent topics in Eugene H. Makela's work include Schizophrenia research and treatment (6 papers), Bipolar Disorder and Treatment (4 papers) and Thyroid Disorders and Treatments (2 papers). Eugene H. Makela is often cited by papers focused on Schizophrenia research and treatment (6 papers), Bipolar Disorder and Treatment (4 papers) and Thyroid Disorders and Treatments (2 papers). Eugene H. Makela collaborates with scholars based in United States, South Sudan and United Kingdom. Eugene H. Makela's co-authors include Iftekhar Kalsekar, Stratford Douglas, Virginia Scott, Mayur M. Amonkar, Suresh Madhavan, Jennifer Schumacher, James M. Stevenson, Stephen M. Bloomfield, Marc W. Haut and Erdoǵan Günel and has published in prestigious journals such as Psychiatry Research, Sleep Medicine and Clinical Therapeutics.

In The Last Decade

Eugene H. Makela

21 papers receiving 499 citations

Peers

Eugene H. Makela

PMH

EDM

PHARM

NEURO

Hans Rittmannsberger Austria

J. Caudle United States

Claire Barkley United Kingdom

Louise Carton France

Candy W. Y. Law Canada

André Tapp United States

Christian Barnas Austria

Flemming Mørkeberg Nilsson Denmark

Antonio Campayo Spain

Michael D. Teehan Canada

Hans Rittmannsberger Austria

Eugene H. Makela

341 ×1.5

PMH

38 ×0.3

EDM

57 ×0.7

58 ×0.7

PHARM

71 ×1.0

NEURO

Citations per year, relative to Eugene H. Makela Eugene H. Makela (= 1×) peers Hans Rittmannsberger

Countries citing papers authored by Eugene H. Makela

Since Specialization

Citations

This map shows the geographic impact of Eugene H. Makela's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eugene H. Makela with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eugene H. Makela more than expected).

Fields of papers citing papers by Eugene H. Makela

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eugene H. Makela. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eugene H. Makela. The network helps show where Eugene H. Makela may publish in the future.

Co-authorship network of co-authors of Eugene H. Makela

This figure shows the co-authorship network connecting the top 25 collaborators of Eugene H. Makela. A scholar is included among the top collaborators of Eugene H. Makela based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eugene H. Makela. Eugene H. Makela is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bailey, Anne, Eugene H. Makela, & Kia Åsberg. (2016). Selective Serotonin Reuptake Inhibitor/Serotonin-Norepinephrine Reuptake Inhibitor Use as a Predictor of a Diagnosis of Restless Legs Syndrome. Journal of Psychiatric Practice. 22(4). 263–269. 7 indexed citations

Makela, Eugene H., et al.. (2012). Child Psychiatrists’ Self-Reported Treatment and Monitoring of Children and Adolescents with Major Depressive Disorder. Journal of Psychiatric Practice. 18(4). 253–261. 5 indexed citations

Makela, Eugene H., et al.. (2009). Selective serotonin reuptake inhibitor-induced akathisia. Journal of the American Pharmacists Association. 49(2). e28–e38. 29 indexed citations

Kalsekar, Iftekhar, Suresh Madhavan, Mayur M. Amonkar, et al.. (2006). Impact of depression on utilization patterns of oral hypoglycemic agents in patients newly diagnosed with type 2 diabetes mellitus: A retrospective cohort analysis. Clinical Therapeutics. 28(2). 306–318. 27 indexed citations

Kalsekar, Iftekhar, Suresh Madhavan, Mayur M. Amonkar, et al.. (2006). Depression in Patients with Type 2 Diabetes: Impact on Adherence to Oral Hypoglycemic Agents. Annals of Pharmacotherapy. 40(4). 605–611. 72 indexed citations

Makela, Eugene H., et al.. (2005). Selective Serotonin-Reuptake Inhibitors in the Treatment of Premature Ejaculation. Annals of Pharmacotherapy. 39(7-8). 1296–1301. 19 indexed citations

Makela, Eugene H., et al.. (2005). Medication Utilization Patterns and Methods of Suicidality in Borderline Personality Disorder. Annals of Pharmacotherapy. 40(1). 49–52. 16 indexed citations

Makela, Eugene H., et al.. (2004). SSRI-Induced Apathy Syndrome: A Clinical Review. Journal of Psychiatric Practice. 10(3). 196–199. 125 indexed citations

Makela, Eugene H., et al.. (2004). Concomitant use of modafinil and tranylcypromine in a patient with narcolepsy: a case report. Sleep Medicine. 5(5). 509–511. 9 indexed citations

10.

Elnicki, D. Michael, et al.. (2004). Utilizing CIWA-Ar to assess use of benzodiazepines in patients vulnerable to alcohol withdrawal syndrome.. PubMed. 100(1). 21–5. 9 indexed citations

11.

Aboraya, Ahmed, et al.. (2004). Hyperprolactinemia associated with risperidone: a case report and review of literature.. PubMed. 1(3). 29–31. 6 indexed citations

12.

Kalsekar, Iftekhar, Eugene H. Makela, & Karen E. Moeller. (2003). Analysis of West Virginia medicaid claims data for the prevalence of medical conditions and use of drugs likely to cause QT prolongation in patients with schizophrenia. Current Therapeutic Research. 64(8). 538–550. 3 indexed citations

13.

Makela, Eugene H., et al.. (2003). Enhancing Treatment of Bipolar Disorder Using the Patient's Belief System. Annals of Pharmacotherapy. 37(4). 543–545. 5 indexed citations

14.

Makela, Eugene H., et al.. (2003). Branded versus Generic Clozapine for Treatment of Schizophrenia. Annals of Pharmacotherapy. 37(3). 350–353. 15 indexed citations

15.

Schumacher, Jennifer, et al.. (2003). Multiple Antipsychotic Medication Prescribing Patterns. Annals of Pharmacotherapy. 37(7-8). 951–955. 40 indexed citations

16.

Makela, Eugene H., et al.. (2000). Hypothyroidism and Depression: A Therapeutic Challenge. Annals of Pharmacotherapy. 34(10). 1142–1145. 21 indexed citations

17.

Haut, Marc W., et al.. (1996). On the nature of Wisconsin Card Sorting Test performance in schizophrenia. Psychiatry Research. 65(1). 15–22. 60 indexed citations

18.

Makela, Eugene H., et al.. (1994). Alcohol Withdrawal: What is the Benzodiazepine of Choice?. Annals of Pharmacotherapy. 28(1). 67–71. 38 indexed citations

19.

Makela, Eugene H.. (1994). Understanding Chronic Fatigue Syndrome. American Pharmacy. 34(4). 45–56. 18 indexed citations

20.

Makela, Eugene H., Sharon Davis, William A. Miller, et al.. (1988). Effect of data collection method on results of serum digoxin concentration audit. American Journal of Health-System Pharmacy. 45(1). 126–130. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact